Simultaneous determination of triptolide and its prodrug MC002 in dog blood by LC–MS/MS and its application in pharmacokinetic studies

Tripterygium wilfordii HOOK F (TWHF) is a traditional Chinese medicine used in the treatment of various autoimmune diseases and inflammatory disorders including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and skin diseases. Triptolide (TP) is one of the main active ingredients of...

Full description

Saved in:
Bibliographic Details
Published inJournal of ethnopharmacology Vol. 150; no. 1; pp. 131 - 137
Main Authors Zhuang, Xiao-Mei, Liu, Ping-Xia, Zhang, Yu-Jie, Li, Chang-Kun, Li, Ying, Wang, Juan, Zhou, Lei, Zhang, Zhen-Qing
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 28.10.2013
Elsevier Ireland Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tripterygium wilfordii HOOK F (TWHF) is a traditional Chinese medicine used in the treatment of various autoimmune diseases and inflammatory disorders including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and skin diseases. Triptolide (TP) is one of the main active ingredients of this traditional Chinese medicine. MC002 is a novel semi-synthetic derivate of TP which is highly water soluble, acts as a prodrug and is converted to TP in vivo. A sensitive, rapid method for the simultaneous determination of TP and its chemo-unstable prodrug MC002 in dog blood was developed and validated using electrospray ionization (ESI) liquid chromatography–tandem mass spectrometry (LC–MS/MS). Using this method, a pharmacokinetic study of MC002 and TP following an intravenous drip infusion of 0.2mg/kg MC002 in dogs was performed. Chemo-degradation of the prodrug in blood samples was inhibited by the addition of a small amount of sodium fluoride solution before using liquid–liquid extraction with ethyl acetate. The concentrations of MC002 and TP in dog blood were determined using the LC–MS/MS method. The quantitative method showed good precision and stability and is suitable for the assay of biological samples. The pharmacokinetic study showed that the elimination of MC002 was faster than that of TP, and the concentrations and AUC0−t values of TP were higher than MC002. MC002 can rapidly convert to TP in vivo. This validated method was successfully applied in a pharmacokinetic study of MC002 following an intravenous drip infusion in dogs. With the development of this new prodrug of TP as a promising anti-cancer drug, this method is suitable for its further analysis in clinical studies. [Display omitted]
Bibliography:http://dx.doi.org/10.1016/j.jep.2013.08.018
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-8741
1872-7573
1872-7573
DOI:10.1016/j.jep.2013.08.018